申请人:Tsantrizos S. Youla
公开号:US20050014791A1
公开(公告)日:2005-01-20
The use of a compound of formula (II):
or its enantiomers or diastereoisomers thereof, or salts or pharmaceutically-acceptable esters thereof, in the treatment or prevention of a papilloma virus infection, particularly human papilloma virus in a mammal, wherein R
11
; X
4
; X
5
; X
6
; R
13
; R
14
; W; Z; Y; T; and R
18
are defined herein.
The present invention also provides novel compounds, pharmaceutical compositions and methods for using these compounds and compositions in the treatment or prevention of papilloma virus infection. More particularly, the present invention provides compounds, compositions and methods for inhibiting papilloma virus DNA replication by interfering with the E1-E2 protein-protein interaction essential for viral DNA replication.
使用化合物式(II)的化合物,其对映体或二对映异构体或其盐或药学上可接受的酯,在哺乳动物中治疗或预防乳头瘤病毒感染,特别是人类乳头瘤病毒感染。其中R11; X4; X5; X6; R13; R14; W; Z; Y; T; 和R18在此定义。本发明还提供了新的化合物、制药组合物和使用这些化合物和组合物治疗或预防乳头瘤病毒感染的方法。更具体地,本发明提供了通过干扰对病毒DNA复制至关重要的E1-E2蛋白质相互作用来抑制乳头瘤病毒DNA复制的化合物、组合物和方法。